Prognosis of brief psychotic episodes a meta-analysis

JAMA Psychiatry

Volumn 73, Issue 3, 2016, Pages 211-220

  Fusar Poli, Paolo ^a,b,c   Cappucciati, Marco ^a,c   Bonoldi, Ilaria ^a,c   Hui, L M Christy ^d   Rutigliano, Grazia ^a   Stahl, Daniel R ^a   Borgwardt, Stefan ^e   Politi, Pierluigi ^c   Mishara, Aaron L ^f   Lawrie, Stephen M ^g   Carpenter, William T ^h,i   McGuire, Philip K ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b SOUTH LONDON AND MAUDSLEY NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF PAVIA   (Italy)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e UNIVERSITY OF BASEL   (Switzerland)

^f Chicago School of Professional Psychology   (United States)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

^h UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

ⁱ Veterans Integrated Service Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRIEF PSYCHOTIC DISORDER; FOLLOW UP; HUMAN; MENTAL PATIENT; META ANALYSIS; PROGNOSIS; RECURRENT DISEASE; REMISSION; REVIEW; RISK; SYMPTOM; ACUTE DISEASE; ADULT; DIFFERENTIAL DIAGNOSIS; FEMALE; MALE; PREDICTIVE VALUE; PSYCHOLOGY; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

ACUTE DISEASE; ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PSYCHOTIC DISORDERS; RECURRENCE; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84962607212     PISSN: 2168622X     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamapsychiatry.2015.2313     Document Type: Review

References (86)

1. World Health Organization. International Statistical Classification of Diseases, 10th Revision. Geneva, Switzerland: World Health Organization; 1992.
2. Pillmann F, Marneros A. Brief and acute psychoses: the development of concepts. Hist Psychiatry. 2003;14(54, pt 2):161-177.
3. Kahlbaum L. Die Gruppirung psychischer Krankheiten. Danzig, Germany: Kafemann; 1863.
4. Kraepelin E. Psychiatrie: Ein Lehrbuch für Studirende und Aerzte: 5, vollständig umgearbeitete Auflage. Leipzig, Germany: Barth; 1896.
5. Magnan V, LegrainM. Les Dégénérés: Etat Mental et Syndromes Épisodiques. Paris, France: Rueff et Cie; 1895.
6. Leonhard K. Die Aufteilung der endogenen Psychosen: 1. Berlin, Germany: Akademie-Verlag; 1957.
7. Jaspers K. General Psychopathology. Chicago, IL: University of Chicago Press; 1963.
8. Störring GE, Suchenwirth R, Völkel H. Emotionalität und cycloide Psychosen. Psychiatr Neurol Med Psychol (Leipz). 1962;14:85-97.
9. Mitsuda H. The concept of "atypical psychoses" from the aspect of clinical genetics. Acta Psychiatr Scand. 1965;41(3):372-377.
10. Langfeldt G. The Schizophreniform States. Copenhagen, Denmark: E Munksgaard; 1939.
11. Yung AR, McGorry PD, McFarlane CA, Jackson HJ, Patton GC, Rakkar A. Monitoring and care of young people at incipient risk of psychosis. Schizophr Bull. 1996;22(2):283-303.
12. Kistler JP, Ropper AA, Martin JB. Cerebrovascular diseases. In: Wilson JD, Braunwald E, Isselbacher KJ, et al, eds. Harrison's Principles of Internal Medicine. New York, NY: McGraw-Hill; 1991: 1977-2002.
13. Miller TJ, McGlashan TH, Rosen JL, et al. Prodromal assessment with the Structured Interview for Prodromal Syndromes and the Scale of Prodromal Symptoms: predictive validity, interrater reliability, and training to reliability. Schizophr Bull. 2003;29(4):703-715.
14. Marneros A, Pillmann P. Acute and Transient Psychoses. Cambridge, England: Cambridge University Press; 2004.
15. Morel BA. Traité des dégénérescences de l'espèce humaine. Paris, France: Chez Bailliere; 1857.
16. Ey H. Bouffées délirantes' et psychoses hallucinatoires aiguës: etudes psychiatriques. In: Structure des Psychoses Aigues et Déstructuration de la Conscience. Vol 3. Paris, France: Desclée de Brower; 1954:203-324.
17. Pichot P. The concept of bouffée délirante with special reference to the Scandinavian concept of reactive psychosis. Psychopathology. 1986;19(1-2): 35-43.
18. Mitsuda H. Klinisch-erbbiologische Untersuchung der Schizophrenie [in Japanese with German abstract]. Psychiatr Neurol (Basel). 1942; 46:298-362.
19. Jaspers K. Allgemeine Psychopathologie. Berlin, Germany: Springer; 1913.
20. Wimmer A. Psykogene sindssygdomsformer. In:Wimmer A, ed. Jubilee Publication, St. Hans Hospital 1816-1916. Copenhagen, Denmark: Gad; 1916:85-216.
21. Strömgren E. Psychogene Psychosen. Nervenarzt. 1986;57:88-95.
22. Faergeman P. Psychogenic Psychoses. London, England: Butterworth; 1963.
23. Wernicke C. Grundriss der Psychiatrie in klinischen Vorlesungen. Leipzig, Germany: Thieme; 1900.
24. Kleist K. Über die gegenwärtigen Strömungen in der klinischen Psychiatrie. Allegemeine Zeitschrift für Psychiatrie. 1924;81:389-393.
25. Schröder P. Über Degenerationspsychosen (Metabolische Erkrankungen). Z Gesamte Neurol Psychiatr. 1926;105:539-547.
26. Perris C, Brockington IF. Cycloid psychosis and their relation to the major psychosis. In: Perris C, Struwe D, Janson B, eds. Biological Psychiatry. Amsterdam, the Netherlands: Elsevier; 1981:447-450.
27. Staehelin JE. Zur Frage der Emotionspsychosen. Bull Schweiz Akad Med Wiss. 1946;2:121-130.
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association; 2013.
29. McGlashan TH,Walsh B,Wood SJ. The Psychosis-Risk Syndrome: Handbook for Diagnosis and Follow-up. New York, NY:Oxford University Press; 2010.
30. Yung AR, Phillips LJ, Yuen HP,McGorry PD. Comprehensive Assessment of At-Risk Mental State. Parkville, Australia: PACE Clinic, ORYGEN Research Centre, Dept of Psychiatry, University ofMelbourne; 2006.
31. Pillmann F, Marneros A. Longitudinal follow-up in acute and transient psychotic disorders and schizophrenia. Br J Psychiatry. 2005;187:286-287.
32. Pillmann F, Haring A, Balzuweit S, Marneros A. A comparison of DSM-IV brief psychotic disorder with "positive" schizophrenia and healthy controls. Compr Psychiatry. 2002;43(5):385-392.
33. Pillmann F, Haring A, Balzuweit S, Blöink R, Marneros A. The concordance of ICD-10 acute and transient psychosis and DSM-IV brief psychotic disorder. Psychol Med. 2002;32(3):525-533.
34. Castagnini A, Foldager L. Epidemiology, course and outcome of acute polymorphic psychotic disorder: implications for ICD-11. Psychopathology. 2014;47(3):202-206.
35. Fusar-Poli P, Borgwardt S, Bechdolf A, et al. The psychosis high-risk state: a comprehensive state-of-the-art review. JAMA Psychiatry. 2013;70 (1):107-120.
36. Yung AR, Yuen HP,McGorry PD, et al. Mapping the onset of psychosis: the Comprehensive Assessment of At-Risk Mental States.Aust N Z J Psychiatry. 2005;39(11-12):964-971.
37. WolfME, Held VE, Hennerici MG. Risk scores for transient ischemic attack. Front Neurol Neurosci. 2014;33:41-68.
38. Yung AR, Phillips LJ, Yuen HP,McGorry PD. Risk factors for psychosis in an ultra high-risk group: psychopathology and clinical features. Schizophr Res. 2004;67(2-3):131-142.
39. Fusar-Poli P, CappucciatiM, Borgwardt S, et al. Heterogeneity of psychosis risk within individuals at clinical high risk: ameta-analytical stratification [published online December 30, 2015]. JAMA Psychiatry. doi:10.1001/jamapsychiatry.2015.2324.
40. Winton-Brown TT, Harvey SB, McGuire PK. The diagnostic significance of BLIPS (brief limited intermittent psychotic symptoms) in psychosis. Schizophr Res. 2011;131(1-3):256-257.
41. Schultze-Lutter F, Schimmelmann BG, Ruhrmann S. The near Babylonian speech confusion in early detection of psychosis. Schizophr Bull. 2011; 37(4):653-655.
42. Zhang JP, Gallego JA, Robinson DG, Malhotra AK, Kane JM, Correll CU. Efficacy and safety of individual second-generation vs first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis. Int J Neuropsychopharmacol. 2013;16(6):1205-1218.
43. Fusar-Poli P, Yung AR, McGorry P, van Os J. Lessons learned from the psychosis high-risk state: towards a general staging model of prodromal intervention. Psychol Med. 2014;44(1):17-24.
44. StaffordMR, Jackson H, Mayo-Wilson E, Morrison AP, Kendall T. Early interventions to prevent psychosis: systematic review and meta-analysis. BMJ. 2013;346:f185.
45. Kapur S, Phillips AG, Insel TR.Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it? Mol Psychiatry. 2012; 17(12):1174-1179.
46. Kendell R, Jablensky A. Distinguishing between the validity and utility of psychiatric diagnoses. Am J Psychiatry. 2003;160(1):4-12.
47. Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting: Meta-analysis Observational Studies in Epidemiology (MOOSE) group. JAMA. 2000;283 (15):2008-2012.
48. Riecher-Rössler A, Aston J, Ventura J, et al. The Basel Screening Instrument for Psychosis (BSIP): development, structure, reliability and validity [in German]. Fortschr Neurol Psychiatr. 2008;76(4): 207-216.
49. Castagnini A, Berrios GE. Acute and transient psychotic disorders (ICD-10 F23): a review from a European perspective. Eur Arch Psychiatry Clin Neurosci. 2009;259(8):433-443.
50. Correll CU, Smith CW, Auther AM, et al. Predictors of remission, schizophrenia, and bipolar disorder in adolescents with brief psychotic disorder or psychotic disorder not otherwise specified considered at very high risk for schizophrenia. J Child Adolesc Psychopharmacol. 2008;18(5):475-490.
51. Memon MA. Brief psychotic disorder treatment & management. Medscape News & Perspective website. http://emedicine.medscape.com/article /294416-treatment#d1. Published September 3, 2013. Accessed October 30, 2015.
52. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. BMJ. 2009;339:b2535.
53. Nyaga VN, ArbynM, Aerts M. Metaprop: a Stata command to perform meta-analysis of binomial data. Arch Public Health. 2014;72(1):39.
54. Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857-872.
55. Freeman MF, Tukey JW. Transformations related to the angular and the square root. Ann Math Stat. 1950;21:607-611.
56. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7(3):177-188.
57. Lipsey M, Wilson D. Practical Meta-analysis. Thousand Oaks, CA: Sage Publications; 2000.
58. Steichen T. METANINF: Stata Module to Evaluate Influence of a Single Study in Meta-analysis Estimation, Statistical Software Components S419201. Boston, MA: Dept of Economics, Boston College; 2001.
59. Sterne JA, Egger M, Smith GD. Systematic reviews in health care: investigating and dealing with publication and other biases inmeta-analysis. BMJ. 2001;323(7304):101-105.
60. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-634.
61. Harbord R, Harris R, Sterne A. Updated tests for small-study effects inmeta-analyses. Stata J. 2009;9(2):197-210.
62. Möller HJ, Jäger M, Riedel M, Obermeier M, Strauss A, Bottlender R. The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: assessing courses, types and time stability of diagnostic classification. Eur Psychiatry. 2011;26(4): 231-243.
63. Salvatore P, Baldessarini RJ, Tohen M, et al. McLean-Harvard International First-Episode Project: two-year stability of ICD-10 diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry. 2011;72(2):183-193.
64. Heslin M, Lomas B, Lappin JM, et al. Diagnostic change 10 years after a first episode of psychosis. Psychol Med. 2015;45(13):2757-2769.
65. Fusar-Poli P, Van Os J. Lost in transition: setting psychosis threshold in prodromal research. Acta Psychiatr Scand. 2013;127(3):248-252.
66. Fusar-Poli P, CappucciatiM, Rutigliano G, et al. At risk or not at risk? meta-analysis of the prognostic accuracy of psychometric interviews for psychosis prediction.World Psychiatry. 2015;14(3): 322-332.
67. Yung AR, Nelson B, Thompson A,Wood SJ. The psychosis threshold in ultra high risk (prodromal) research: is it valid? Schizophr Res. 2010;120(1-3):1-6.
68. Kempton MJ, Bonoldi I, Valmaggia L,McGuire P, Fusar-Poli P. Speed of psychosis progression in people at ultra-high clinical risk: a complementary meta-analysis. JAMA Psychiatry. 2015;72(6):622-623.
69. Queirazza F, Semple DM, Lawrie SM. Transition to schizophrenia in acute and transient psychotic disorders. Br J Psychiatry. 2014;204:299-305.
70. Fusar-Poli P, Frascarelli M, Valmaggia L, et al. Antidepressant, antipsychotic and psychological interventions in subjects at high clinical risk for psychosis: OASIS 6-year naturalistic study. Psychol Med. 2015;45(6):1327-1339.
71. Mrazek P, Haggerty R. Reducing Risks for Mental Disorders: Frontiers for Preventive Intervention Research.Washington, DC: National Academy Press; 1994.
72. Gordon RS Jr. An operational classification of disease prevention. Public Health Rep. 1983;98(2): 107-109.
73. World Health Organization. Prevention of Mental Disorders: Effective Interventions and Policy Options. Geneva, Switzerland: Dept of Mental Health and Substance Abuse, WHO; 2004.
74. Fusar-Poli P, CarpenterW,Wood S, McGlashan T. Attenuated psychosis syndrome: ready for DSM-5.1? Annu Rev Clin Psychol. 2014;10:155-192.
75. Simon AE, Umbricht D, Lang UE, Borgwardt S. Declining transition rates to psychosis: the role of diagnostic spectra and symptom overlaps in individuals with attenuated psychosis syndrome. Schizophr Res. 2014;159(2-3):292-298.
76. Cornblatt BA, Carrion RE, Auther A, et al. Psychosis prevention: a modified clinical high risk perspective from the Recognition and Prevention (RAP) Program. Am J Psychiatry. 2015;172(10):986-994.
77. McGorry PD. Early clinical phenotypes, clinical staging, and strategic biomarker research: building blocks for personalized psychiatry. Biol Psychiatry. 2013;74(6):394-395.
78. Heckers S, Barch DM, Bustillo J, et al. Structure of the psychotic disorders classification in DSM-5. Schizophr Res. 2013;150(1):11-14.
79. Tandon R, GaebelW, Barch DM, et al. Definition and description of schizophrenia in the DSM-5. Schizophr Res. 2013;150(1):3-10.
80. Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU. Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics. Mol Psychiatry. 2013;18(1):53-66.
81. Leucht S, Barnes TR, KisslingW, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia with new-generation antipsychotics: a systematic review and exploratorymeta-analysis of randomized, controlled trials. Am J Psychiatry. 2003;160(7):1209-1222.
82. Leucht S, TardyM, Komossa K, et al. Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis. Lancet. 2012;379(9831):2063-2071.
83. Jørgensen P, Bennedsen B, Christensen J, Hyllested A. Acute and transient psychotic disorder: a 1-year follow-up study. Acta Psychiatr Scand. 1997;96(2):150-154.
84. Marneros A, Pillmann F, Haring A, Balzuweit S, Blöink R. What is schizophrenic in acute and transient psychotic disorder? Schizophr Bull. 2003; 29(2):311-323.
85. Altman DG, Bland JM. Absence of evidence is not evidence of absence. BMJ. 1995;311(7003):485.
86. Marneros A, Pillmann F, Haring A, Balzuweit S, Blöink R. The relation of "acute and transient psychotic disorder" (ICD-10 F23) to bipolar schizoaffective disorder. J Psychiatr Res. 2002;36 (3):165-171.